Abstract
Revised Centers for Disease Control and Prevention recommendations on HIV testing now promote testing of most risk groups. However, positive results for low-risk individuals are more likely to be false positives than for high-risk individuals, making clear communication of test results even more imperative. In a study, we evaluated current counseling of low-risk test recipients via a sample of 29 HIV hotline counselors from U.S. state and national hotlines. 100% of counselors interviewed failed to provide an accurate conditional HIV risk for low-risk women, but were more likely than a 1998 German sample to report that false positives could occur. In a second study, undergraduates read idealized transcripts of interviews with HIV counselors and computed conditional risk for a low-risk individual. The natural frequency format offered a small but significant improvement in conditional reasoning, comparable to the effect of numerical literacy. Applications for ecologically valid numerical presentations of risk and implications for numeracy are discussed.
Keywords: Bayesian reasoning, conditional risk, HIV counseling, HIV testing, numeracy, risk communication.
Current HIV Research
Title:Communicating HIV Results to Low-Risk Individuals: Still Hazy After All These Years
Volume: 13 Issue: 5
Author(s): Katrina M. Ellis and Gary L. Brase
Affiliation:
Keywords: Bayesian reasoning, conditional risk, HIV counseling, HIV testing, numeracy, risk communication.
Abstract: Revised Centers for Disease Control and Prevention recommendations on HIV testing now promote testing of most risk groups. However, positive results for low-risk individuals are more likely to be false positives than for high-risk individuals, making clear communication of test results even more imperative. In a study, we evaluated current counseling of low-risk test recipients via a sample of 29 HIV hotline counselors from U.S. state and national hotlines. 100% of counselors interviewed failed to provide an accurate conditional HIV risk for low-risk women, but were more likely than a 1998 German sample to report that false positives could occur. In a second study, undergraduates read idealized transcripts of interviews with HIV counselors and computed conditional risk for a low-risk individual. The natural frequency format offered a small but significant improvement in conditional reasoning, comparable to the effect of numerical literacy. Applications for ecologically valid numerical presentations of risk and implications for numeracy are discussed.
Export Options
About this article
Cite this article as:
Ellis M. Katrina and Brase L. Gary, Communicating HIV Results to Low-Risk Individuals: Still Hazy After All These Years, Current HIV Research 2015; 13 (5) . https://dx.doi.org/10.2174/1570162X13666150511125629
DOI https://dx.doi.org/10.2174/1570162X13666150511125629 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
Management of HIV: Management of HIV: old challenges and new needs
The aim of this thematic issue is to provide the most recent updates regarding the effective management of HIV infection. Antiretroviral therapy (ART) has significantly decreased HIV-related mortality, leading to an enhancement in the quality of life and life expectancy for people living with HIV (PLWH). Despite the numerous advancements ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Stochastic Neighbor Embedding Algorithm and its Application in Molecular Biological Data
Current Bioinformatics Patent Selections:
Recent Patents on Biomarkers The Role of Integrin-Mediated Cell Adhesion in Atherosclerosis: Pathophysiology and Clinical Opportunities
Current Pharmaceutical Design Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Metabolomics as a Functional Tool in Screening Gastro Intestinal Diseases: Where are we in High Throughput Screening?
Combinatorial Chemistry & High Throughput Screening Targeting Ion Channels in Cancer: A Novel Frontier in Antineoplastic Therapy
Current Medicinal Chemistry Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease
Current Alzheimer Research Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Anti-Aging Property of G2013 Molecule as a Novel Immunosuppressive Agent on Enzymatic and Non-Enzymatic Oxidative Stress Determinants in Rat Model
Current Drug Discovery Technologies The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders
Central Nervous System Agents in Medicinal Chemistry Vitamin D and Non-coding RNAs: New Insights into the Regulation of Breast Cancer
Current Molecular Medicine Vitamin D Receptor Agonists: Opportunities and Challenges in Drug Discovery
Current Topics in Medicinal Chemistry The Medical and Medico-legal Complications of Bulimia Nervosa : Treatments and Complications
Current Women`s Health Reviews Tumour Reactions to Hypoxia
Current Molecular Medicine Endomorphin Derivatives with Improved Pharmacological Properties
Current Medicinal Chemistry Ductal Carcinoma In Situ: Clinical Trials Update and Resolving Controversies
Current Cancer Therapy Reviews Subject Index to Volume 5
Current Pharmaceutical Biotechnology Treatment of Estrogen Receptor-Positive Breast Cancer
Current Medicinal Chemistry